发明名称 METHOD FOR SETTING DILTIAZEM DOSE FOR TREATMENT OF PATIENTS WITH POST-INFARCT CARDIOSCLEROSIS AND CIRCULATION INSUFFICIENCY OF FUNCTIONAL CLASS 2
摘要 FIELD: medicine, cardiology. ^ SUBSTANCE: invention relates to treatment of patients with post-infarct cardiosclerosis with circulation insufficiency of functional class 2. Method involves using diltiazem with individual setting doses. Method involves carrying out the simplified 2 h oral tolerance test to glucose. Diltiazem is prescribed in the initial dose 90 mg and in the maintenance dose 45 mg in positive result of test. In negative result of test diltiazem is prescribed in the initial dose 180 mg and in the maintenance dose 90 mg. Method provides enhancing effectiveness in treatment of patients with post-infarct cardiosclerosis with circulation insufficiency due to the more precise individual setting dose of the preparation and reducing frequency in arising adverse effects. ^ EFFECT: improved method for setting, enhanced effectiveness of treatment. ^ 2 tbl, 2 ex
申请公布号 RU2255740(C2) 申请公布日期 2005.07.10
申请号 RU20030120315 申请日期 2003.07.02
申请人 发明人 TEPLJAKOV A.T.;MAMCHUR S.E.;VOVCHENKO I.A.
分类号 A61K31/554;A61P9/10 主分类号 A61K31/554
代理机构 代理人
主权项
地址